June 9, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

Attention: Ada D. Sarmento

Re:	Moleculin Biotech, Inc.
	Registration Statement on Form S-3
	Registration No. 333-256627

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Moleculin Biotech, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 P.M. (Eastern Time) on June 11, 2021, or as soon thereafter as possible on such date.

Very truly yours,
Moleculin Biotech, Inc.
By:	/s/ Jonathan Foster
	Name: Jonathan Foster
	Title: Chief Financial Officer